S1 E3: ADHD Across Life Transitions: Practical Approaches for Primary Care w/ Dr. Elisabeth Baerg Hall

Guest: Dr. Elizabeth Baerg HallHost: Dr. Chris MorrowProducer: Craig FergusonMusic: "Stand With Me" by Adrian Walther licensed via SoundStripeEpisode Timestamps• [00:00] - Introduction and episode overview• [02:03] - Life transitions and when ADHD becomes visible in adults• [04:14] - How ADHD can be masked by structure and support systems• [05:21] - Red flags for ADHD in primary care settings• [08:54] - Who can diagnose ADHD and what tools are available• [12:05] - The importance of impairment in diagnosis and avoiding overdiagnosis• [16:36] - Common comorbidities: Anxiety, depression, and bipolar disorder• [19:39] - ADHD and substance use disorder• [21:26] - Barriers to diagnosis and treatment: Stigma and misconceptions about stimulants• [24:07] - Inequities in access to care, including Indigenous patients• [26:26] - Challenges for rural patients and older adults with ADHD• [29:00] - Resources and support in BC: CADRA, Shared Care, and Skills for Success• [30:56] - ADHD pathways and UBC CPD educational opportunities• [32:59] - Closing remarks and conference information• [33:52] - Knowledge nugget: The history of psychostimulantsStudies & Research Mentioned• CADDRA – Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines, 4.1 Edition. Toronto, ON: CADDRA; 2020. Accessed January 13, 2026. https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf• Centers for Disease Control and Prevention. Diagnosing ADHD. Updated 2024. Accessed January 13, 2026. https://www.cdc.gov/adhd/diagnosis/index.html• The MTA Cooperative Group: A 14-Month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD) . Arch Gen Psychiatry 1999;56:1073-1086.• The MTA Cooperative Group: Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999;56:1088-1096.• Molina BSG, Kipp HL, Joseph HM, et al. Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training. Acad Pediatr. 2020;20(1):119-127. doi:10.1016/j.acap.2019.06.002• National Institute of Mental Health. The Multimodal Treatment of Attention Deficit Hyperactivity Disorder Study (MTA): Questions and Answers. Revised November 2009. National Institute of Mental Health website. Accessed January 13, 2026. https://www.nimh.nih.gov/funding/clinical-research/practical/mta/the-multimodal-treatment-of-attention-deficit-hyperactivity-disorder-study-mtaquestions-and-answers• Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010;49(3):217-28.e283.(C) 2025 UBC Medicine Learning Network Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.